1. |
裴雪濤. 細胞粘附分子與腫瘤的發生及轉移. 中國病理生理學雜志, 1997; 13(1)∶103.
|
2. |
李樹玲. 中國常見惡性腫瘤診治規范·乳腺癌. 北京: 北京醫科大學、中國協和醫科大學聯合出版社, 1990∶59~60.
|
3. |
周同, 宋長玲. 細胞粘附分子、粘附蛋白與腫瘤轉移. 中國腫瘤生物治療雜志, 1995; 2(3)∶232.
|
4. |
陳金聯, 周同. 選擇素與腫瘤轉移研究進展. 生命科學, 1996; 8(1)∶31.
|
5. |
Toii A, Nakayama A, Harada A, et al. Expression of the CD15 antigen in hepatocellular carcinoma. Cancer, 1993; 71(12)∶3864.
|
6. |
Brooks SA, Leathem AJC. Expression of the CD15 antigen (Lewis χ) in breast cancer. Histochem J, 1995; 27(9)∶689.
|
7. |
Nakagoe T, Fukushima K, Hirota M, et al. Immunohistochemical expression of sialyl Lex antigen in relation to survival of patients with colorectal carcinoma. Cancer, 1993; 72(8)∶2323.
|
8. |
谷化平, 胡海霞, 尚培中. 細胞粘附分子CD15在膽囊癌組織中的表達. 中國腫瘤臨床與康復, 1998; 5(6)∶19.
|
9. |
Neuhold N, Langle F, Gnan M, et al. Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinoma. J Cancer Res Clin Oncol, 1992; 118(8)∶629.
|
10. |
Konety BR, Bullou B, Jaffe R, et al. Expression of SSEA1 (Lewis χ) on transitional cell carcinoma of the bladder. Urol Int, 1997; 58(2)∶69.
|